A Clinicopathological Study of Resected Non-small Cell Lung Cancers 2 cm or Less in Diameter: a Prognostic Assessment

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2010 Jul 28

PMID 20661664

Citations 12

Authors

Chun-Lei Shi

Xue-Yan Zhang

Bao-Hui Han

Wei-Zhong He

Jie Shen

Tian-Qing Chu

Affiliations

Soon will be listed here.

Abstract

The detection and diagnosis of small-sized (2 cm or less) non-small cell lung cancer (NSCLC) has increased with the development of computed tomography (CT). Over 80% of 5-year survival rate has been reported in surgically treated peripheral lung cancer. There are systematic mediastinal and hilar lymph node involvement pleural invasion and intrapulmonary metastasis even with tumor diameter less than 2 cm. The appropriate surgical procedure for such kinds of lung cancer is lobectomy with mediastinal lymph node dissection. To evaluate the prognostic factors and establish the optimal surgical strategy, we analyzed the clinicopathologic features and survival benefit in different tumor size of peripheral small-sized NSCLC. Among the resected lung cancer cases between January 1999 and July 2001, 185 patients were retrospectively analyzed in surgical methods, lymph node involvement, CT scan findings and survival rates. Survival was analyzed by Kaplan-Meier method and log-rank test. Lymph node involvement was recognized in 26(14.05%) patients. There was no statistically significant difference in the incidence of lymph node involvement between tumors 1.6-2.0 cm (17.82%) in diameter than in those 1.0-1.5 cm (11.94%). There was no lymph node metastasis in tumors less than 1.0 cm in diameter. The 5-year survival rates with or without lymph node involvement were 89.98 and 46.15%, respectively, showing significant difference (P=0.000). The overall 5-year survival rate was 83.78%. The 5-year survival rate in tumors 1.6-2.0 cm, 1.0-1.5 cm and less than 1.0 cm in diameter was 80.20, 85.07 and 100%, respectively, and showing significant difference (P=0.035). The 5-year survival rate of 19 patients showing ground-glass opacity (GGO) on CT scan was 94.74% without any metastasis and recurrence after operation. There are systematic mediastinal and hilar lymph node involvement even with tumor diameter less than 2 cm. The results of the present study suggested that systematic lymph node dissection is necessary even for cases with tumor diameter less than 2 cm. However, if the tumor is within 1.0 cm in diameter with obvious GGO showing on chest CT scan, these are good candidates for partial resection without mediastinal lymph node dissection.

Citing Articles

Comparison of lobectomy and sublobar resection for stage I non-small cell lung cancer: a meta-analysis based on randomized controlled trials.

Lu G, Xiang Z, Zhou Y, Dai S, Tong F, Jiang R Front Oncol. 2023; 13:1261263.

PMID: 37860201 PMC: 10582352. DOI: 10.3389/fonc.2023.1261263.

Narrative review of optimal prognostic radiological tools using computed tomography for T1N0-staged non-small cell lung cancer.

Nakada T, Kuroda H J Thorac Dis. 2021; 13(5):3171-3181.

PMID: 34164207 PMC: 8182523. DOI: 10.21037/jtd-20-3380.

The Study of Tumor Volume as a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: An Exploratory Study.

Jia B, Zhang X, Mo Y, Chen B, Long H, Rong T Technol Cancer Res Treat. 2020; 19:1533033820980106.

PMID: 33297855 PMC: 7734535. DOI: 10.1177/1533033820980106.

A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.

Lin W, Huang M, Zhang Z, Chai T, Chen S, Gao L Medicine (Baltimore). 2020; 99(36):e21453.

PMID: 32898994 PMC: 7478443. DOI: 10.1097/MD.0000000000021453.

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer.

Wu Y, Han C, Wang Z, Gong L, Liu J, Chong Y Front Oncol. 2020; 10:1322.

PMID: 32850420 PMC: 7426394. DOI: 10.3389/fonc.2020.01322.

References

Miller D, Rowland C, Deschamps C, Allen M, Trastek V, Pairolero P . Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg. 2002; 73(5):1545-50; discussion 1550-1. DOI: 10.1016/s0003-4975(02)03525-7. View

Fukui T, Katayama T, Ito S, Abe T, Hatooka S, Mitsudomi T . Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer. 2009; 66(3):309-13. DOI: 10.1016/j.lungcan.2009.03.004. View

Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H . Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000; 174(3):763-8. DOI: 10.2214/ajr.174.3.1740763. View

Kondo D, Yamada K, Kitayama Y, Hoshi S . Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg. 2003; 76(2):350-5. DOI: 10.1016/s0003-4975(03)00340-0. View

Patz Jr E, Rossi S, Harpole Jr D, Herndon J, Goodman P . Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000; 117(6):1568-71. DOI: 10.1378/chest.117.6.1568. View

Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R . Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002; 20(4):911-20. DOI: 10.1200/JCO.2002.20.4.911. View

Gomez M, Silvestri G . Lung cancer screening. Am J Med Sci. 2008; 335(1):46-50. DOI: 10.1097/MAJ.0b013e31815d2600. View

Suzuki K, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y . Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 2001; 72(2):352-6. DOI: 10.1016/s0003-4975(01)02748-5. View

Swanson S, Batirel H . Video-assisted thoracic surgery (VATS) resection for lung cancer. Surg Clin North Am. 2002; 82(3):541-59. DOI: 10.1016/s0039-6109(02)00015-4. View

10.

Matsuguma H, Yokoi K, Anraku M, Kondo T, Kamiyama Y, Mori K . Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002; 124(2):278-84. DOI: 10.1067/mtc.2002.122298. View

11.

Pirozynski M . 100 years of lung cancer. Respir Med. 2006; 100(12):2073-84. DOI: 10.1016/j.rmed.2006.09.002. View

12.

Ohtsuka T, Watanabe K, Kaji M, Naruke T, Suemasu K . A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg. 2006; 30(1):160-3. DOI: 10.1016/j.ejcts.2006.03.058. View

13.

Yamato Y, Tsuchida M, Watanabe T, Aoki T, Koizumi N, Umezu H . Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg. 2001; 71(3):971-4. DOI: 10.1016/s0003-4975(00)02507-8. View

14.

Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A . Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002; 26(3):323-9. DOI: 10.1097/00004728-200205000-00001. View

15.

Shennib H, Bogart J, Herndon J, Kohman L, Keenan R, Green M . Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005; 129(4):813-8. DOI: 10.1016/j.jtcvs.2004.05.011. View

16.

Koike T, Yamato Y, Yoshiya K, Kina S, Shimoyama T, Suzuki R . Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer. Jpn J Thorac Cardiovasc Surg. 2003; 51(10):515-9. DOI: 10.1007/s11748-003-0113-5. View

17.

Yoshida J, Nagai K, Yokose T, Nishimura M, Kakinuma R, Ohmatsu H . Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005; 129(5):991-6. DOI: 10.1016/j.jtcvs.2004.07.038. View

18.

Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Kusunoki Y . Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002; 73(2):386-92; discussion 392-3. DOI: 10.1016/s0003-4975(01)03410-5. View

19.

Konaka C, Ikeda N, Hiyoshi T, Tsuji K, Hirano T, Kawate N . Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998; 21(3):185-91. DOI: 10.1016/s0169-5002(98)00057-9. View

20.

Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M . Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006; 131(5):988-93. DOI: 10.1016/j.jtcvs.2005.12.035. View